Representatives from Metfone and FV Hospital signed a strategic cooperation agreement. Photo: FV

According to the agreement signed on April 3, FV and Metfone will jointly implement a closed-loop healthcare model on a digital platform. This is a comprehensive, integrated solution that includes remote consultation, appointment scheduling, transportation assistance, accommodation, interpretation, and payment.

One of the most obvious benefits of this collaborative programme is that it helps Cambodian patients access accurate and reliable health information right from the start.

Through Metfone’s platform, patients can receive online consultations with the FV medical team, enabling them to make appropriate treatment decisions before travelling to Vietnam.

A Metfone representative stated that the selection of FV as a partner was not accidental, but stemmed from the hospital’s international reputation and treatment capabilities, particularly its years of experience in receiving and caring for Cambodian patients.

The combination of Metfone’s telecommunications infrastructure and FV’s internationally standardised healthcare system is expected to create a modern healthcare ecosystem where patients not only receive treatment but also receive companionship throughout their journey.

A Cambodian male patient and his family thank Dr. Phan Van Thai for successfully treating his rare giant duodenal dilation. Photo: FV

FV Hospital: A trusted destination for Cambodian patients for two decades

In fact, for many Cambodians, FV Hospital has been a familiar address for almost 20 years. Each month, the hospital receives approximately 1,000 patients from neighbouring countries, demonstrating a growing level of trust.

Not only does FV possess a team of experienced doctors from both within and outside the country, but it is also a multidisciplinary hospital that meets international JCI standards – one of the world’s leading and most stringent standards for patient quality and safety.

Thanks to its multidisciplinary collaboration, the hospital has successfully treated many complex and rare cases. One such case involved a patient with idiopathic megaduodenum, an extremely rare condition that had left them debilitated for years. Following digestive system reconstruction surgery at FV, the patient made a remarkable recovery.

Or consider the case of a Cambodian woman who experienced severe postpartum haemorrhage, seemingly beyond saving. With the collaboration of over 40 doctors from various specialities, FV identified the cause as a rare blood clotting disorder and successfully treated it promptly, helping the patient recover after more than 30 days.

These stories not only demonstrate professional competence but also reinforce Cambodian patients’ trust in an international hospital right here in Vietnam.

Nguyen Thi Le Thu, Marketing and Business Development director at FV Hospital, stated that FV has had a presence in Cambodia since 2006 with a representative office in Phnom Penh, receiving approximately 1,000 Cambodian patients for examination and treatment each month.

In addition, the hospital also focuses on the patient experience through specialised support services. At FV, Cambodian patients are served at a private counter with a team of Khmer interpreters, ensuring smooth communication and treatment.

At the same time, FV’s representative office in Phnom Penh acts as a bridge, providing counselling and preparation before patients travel to Vietnam.

FV Hospital has a dedicated consultation desk for Cambodian patients. Photo: FV

Alongside service development, FV continuously invests in modern medical technology to improve treatment effectiveness.

Advanced systems such as the da Vinci Xi robotic surgical system, Interventional Catheterisation system (Cathlab), and Brain Navigation have helped increase surgical accuracy, reduce invasiveness, and shorten recovery time.

This is a crucial competitive advantage, enabling FV not only to meet domestic treatment needs but also to become a destination for international patients, especially from Cambodia.

The collaboration between FV and Metfone is not just a single strategic agreement, but a long-term step in building a cross-border healthcare ecosystem.

In the context of increasing international treatment needs, the ‘health corridor’ model is expected to reduce geographical distance, making it easier for Cambodian patients to access high-quality healthcare services, while also easing the burden on the domestic healthcare system.

In the long term, the combination of digital technology and modern medicine will open up new avenues for medical tourism in the region. With its established foundation, FV Hospital – an internationally accredited hospital trusted by a large number of Cambodian patients – is likely to continue playing a pioneering role in this trend.

This signing ceremony therefore not only signifies cooperation between the two organisations, but also represents an important step in the journey to improve the quality of healthcare for communities in Southeast Asia.

FV Hospital's integrated care model proves comprehensive and effective The intensive care unit (ICU) is often seen as the frontline in the battle for patients' lives, where the collaboration between multiple specialities determines success. At FV Hospital, a multidisciplinary, comprehensive care model has demonstrated remarkable effectiveness in treating critically ill patients.

Robotic surgery proves effective for complex thoracic case at FV Hospital Doctors at FV Hospital have used the da Vinci Xi robotic system to successfully remove a large esophageal tumour from a patient while preserving the oesophagus, demonstrating the growing role of robotic surgery in treating complex thoracic conditions.

Robotic surgery advances women's health at FV Hospital A French obstetrician and gynaecologist with more than three decades of experience is applying robotic surgery at FV Hospital to enhance precision, fertility preservation, and recovery outcomes for women.

Building on previous themes ‘Inspiring Tradition’ (2024) and ‘What A Wonderful World’ (2025), this year’s edition focused on future-oriented perspectives, exploring human aspirations amid technological, social, and environmental change. Organisers also introduced a new recognition category for artists with disabilities working in handicrafts, reflecting a broader push towards inclusivity and diversity in artistic expression.

Trinh Phan Anh receives first prize at the 2026 Pan Pacific Hanoi Art Award ceremony. Photo: Pan Pacific Hanoi

A total of 13 winners were honoured at the ceremony for works highlighting social themes and personal resilience. In the 18-30 category, Trinh Phan Anh won first prize with ‘Connection’, followed by Ngo Vinh Thuan and Phan Sy Thang. In the painting category for artists with disabilities, Hoang Thi Thuy took the top award, while Nguyen Thi Dieu Han received the Outstanding Concept Prize in the newly added handicrafts segment.

Among participants under 18, Nguyen Thai An secured first prize with ‘I Cherish’.

Wee Wei Ling, executive director of Sustainability Partnerships, Lifestyle and Asset at Pan Pacific Hotels Group and a member of the jury, said the expanded categories aimed to bring more voices into the platform.

“This year, we received over 200 entries, significantly higher than in previous editions. The theme ‘Horizons of Tomorrow’ invites audiences to reflect on the future through each artist’s perspective, particularly in a time of uncertainty,” she said.

The judging panel included representatives from the Vietnam University of Fine Arts, Hanoi University of Architecture, the Vietnam Fine Arts Association, and international experts. Entries were assessed based on content, form, creativity, and technical execution.

Photo: Pan Pacific Hanoi

The event also featured a performance titled ‘I Am Beautiful. You Too!,’ a collaboration with the Will to Live Center and Chula Fashion, highlighting inclusion through music and fashion. The programme incorporated performances by visually impaired artists and a fashion showcase featuring models with disabilities.

According to the organisers, the competition’s outcomes were supported by sponsors including Singapore Airlines, which awarded cultural experience trips to top winners.

Winning artworks are on display at Pan Pacific Hanoi through the end of May.

Pan Pacific Hanoi Art Award 2025 kicks off with painting competition The Pan Pacific Hanoi Art Award 2025 has officially been launched with the painting competition “What A Wonderful World.”

Pan Pacific Hanoi launches painting contest in collaboration with Vietnam University Fine Arts The Pan Pacific Hanoi introduces 2024 Art Award along with the launch of the "Inspiring Tradition" painting contest, in collaboration with Vietnam University of Fine Arts, aiming to recognise and celebrate the talents of Vietnamese artists with special needs aged 19 to 35.

Pan Pacific Hanoi kicks off 2026 art awards celebrating young and disabled artists Pan Pacific Hanoi, in collaboration with the Vietnam University of Fine Arts (VUFA), launched the third edition of the Pan Pacific Hanoi Art Award in early November.

According to the report, growth in the East Asia and Pacific (EAP) is projected to slow to 4.2 per cent in 2026 from 5 per cent in 2025, as the energy shock due to the Middle East conflict compounds the adverse impact of elevated trade barriers, global policy uncertainty, and domestic economic difficulties.

Growth in China, the region’s largest economy, is projected to decelerate from 5 per cent in 2025 to 4.2 per cent in 2026 and 4.3 per cent in 2027, as weak domestic demand and property sector challenges persist, and the global slowdown dampens export growth. Growth in the rest of the region will slow to 4.1 per cent in 2026 and is projected to rebound to 5 per cent in 2027 as geopolitical tensions ease and uncertainty diminishes. Amid the slowing regional growth, Vietnam is projected to grow 6.3 per cent in 2026 and 7.6 per cent in 2027.

“Growth in East Asia and Pacific continues to outperform much of the world, even in uncertain times,” said Carlos Felipe Jaramillo, vice president for East Asia and Pacific at World Bank. “Yet, sustaining growth levels requires countries to confront structural challenges and seize the opportunity of the digital age to increase productivity and create more jobs.”

The impact of the Middle East conflict depends on each country’s reliance on energy imports, existing vulnerabilities, and economic policy flexibility. Prolonged and intensified conflict may further increase economic distress and reduce regional growth.

A sustained 50 per cent increase in fuel prices could lead to a 3-4 per cent loss in income for households in the region. Targeted support–for both the poor and the vulnerable and the small and medium enterprises–can help those most in need without fiscal strain.

The report shows that economies with stronger buffers–including Cambodia, Indonesia, and Vietnam–have greater capacity to absorb the shock through strategic reserves, domestic refining capacity, or commodity export revenues that provide a natural hedge. Specifically, Vietnam’s fiscal space and domestic refining capacity help contain near‑term macro effects in the event of a short‑lived shock.

“The region’s past resilience is remarkable, but present difficulties could increase economic distress and inhibit productivity growth,” said Aaditya Mattoo, director of research at World Bank Group. “Measured support for people and firms could preserve jobs today, and reviving stalled structural reforms could unleash growth tomorrow.”

The report also identifies surging AI-related exports and investment as a bright spot in 2025, especially in Malaysia, Thailand, and Vietnam. AI could also lead to higher productivity growth, but adoption in EAP remains limited because of gaps in connectivity and skills. Only 13 to 17 per cent of multinational subsidiaries in China and Thailand currently use AI, which is one third of the proportion in industrial countries.

The report’s special focus shows how in specific circumstances industrial policy can help EAP economies boost growth and create more productive jobs. Targeted support for specific industries in South Korea, Malaysia and, more recently, Viet Nam worked because these countries had improved their economic foundations–infrastructure, education and regulatory institutions–and liberalised trade and investment.

Vietnam to lead trade growth in ASEAN Despite tariff headwinds, Vietnam remains among ASEAN’s top export growth performers, supporting expectations of robust gains in employment and wages.

Vietnam GDP projected to grow 7.4 per cent in 2026 The ASEAN+3 Macroeconomic Research Office on April 6 released its annual flagship report, the ASEAN+3 Regional Economic Outlook 2026, projecting Vietnam's GDP growth of 7.4 per cent in 2026.

Vietnam GDP posts second-strongest growth since 2011 Vietnam’s economy delivered one of its strongest growth performances in more than a decade last year, with momentum building steadily through the quarters and peaking at year-end.

The Tax Department issued an official letter on March 31, requesting tax authorities nationwide to intensify management of businesses that have reported losses over multiple years or maintained unusually low profitability.

According to the authority, a number of solutions were implemented in 2025 to enhance tax administration, including measures targeting enterprises declaring repeated losses and thin margins. While these efforts delivered positive results, many businesses continue to exhibit prolonged loss-making positions, raising concerns over potential revenue leakage.

The latest directive requires tax departments at all levels to step up communication and guidance to ensure taxpayers declare fully, accurately, and transparently in line with regulations. Authorities are urged to strengthen warnings and enforcement against violations, particularly those related to transfer pricing and misreporting aimed at reducing tax obligations.

Tax agencies are also tasked with reviewing data and conducting risk analysis to identify enterprises with abnormal tax declarations. Companies deemed high-risk will be placed under close monitoring and subject to inspection, with violations handled strictly in accordance with the law.

In addition, tax authorities are required to intensify reviews of tax filings and payment obligations. Where discrepancies are detected, enterprises must be guided to make timely amendments, while inspections at taxpayers’ premises will be expanded.

A notable feature of the directive is the requirement to develop specialised inspection plans focusing on companies with long-term losses and thin margins. Provincial tax departments, along with the Large Enterprise Tax Department and the E-commerce Tax Department, will conduct inspections directly at company headquarters. In cases where on-site inspections are not feasible, appropriate supervisory measures will be applied to ensure effective oversight.

The implementation timeline is set from April to December 2026. Tax authorities must submit detailed inspection plans for each enterprise under their management in April, provide monthly progress updates, and complete a final report by December. The report will detail additional tax collections, penalties imposed, and common violations identified during the process.

The appended list of 302 enterprises reflects a broad cross-section of Vietnam’s economy, spanning retail, steel, food and beverage, agriculture, manufacturing, and technology.

In retail and food services, companies such as Lotteria Vietnam Co., Ltd. and KFC Vietnam Joint Venture Co., Ltd. are included. The steel sector features Pomina Flat Steel JSC and Formosa Ha Tinh Steel Corporation, alongside other manufacturers.

In technology and telecommunications, VNPT Technology Corporation and VNPT E-Payment JSC are among those identified.

The list includes a wide range of domestic and foreign-invested manufacturers such as TOTO Vietnam Co., Ltd., Schaeffler Vietnam Co., Ltd., and Sanhua Vietnam Co., Ltd., alongside enterprises operating in logistics, real estate, energy, retail, and import-export.

The inclusion of large corporations across multiple sectors highlights a shift towards more risk-based tax management, with authorities focusing on enterprises whose financial performance may not align with their scale of operations. Particularly notable is the presence of firms in sectors typically associated with stronger profitability, suggesting that cost structures and internal arrangements may be delivering a significant blow to margins.

At the same time, differences in the composition of the list indicate varying compliance profiles and financial reporting practices across industries.

Under a decision announced on April 6, Saigon – Bac Giang Industrial Park JSC has been selected as the investor for the Van Canh 1 and Van Canh 2 wind power farms.

The Van Canh 1 project, located in Canh Lien commune, carries an investment of more than VND6.9 trillion ($276.20 million) and will have a designed capacity of 160MW, generating an estimated 502 million kWh per year. Meanwhile, Van Canh 2, spanning Canh Lien and Van Canh communes, will require over $310.80 million in investment, with a capacity of 180MW and expected annual output of 623.2 million kWh.

Both projects will operate for 50 years and are scheduled for completion and commercial operation in the fourth quarter of 2028.

Notably, the provincial authority has introduced stringent conditions on ownership changes. Gia Lai People’s Committee requires that investors must not transfer project ownership, equity, or capital contributions in any form without prior written approval.

“Any violation may result in the termination of the scheme without compensation,” the authority said.

In addition, investors are required to ensure that all equipment used has clear origins and complies with regulatory inspection standards, while land use must adhere strictly to approved purposes, avoiding any impact on natural forest areas or defence land.

The move reflects growing concern among local authorities over speculative practices in the renewable energy sector, where projects are acquired primarily for resale rather than long-term development.

By tightening transfer rules, Gia Lai aims to ensure that only capable investors proceed with implementation, thereby supporting more sustainable development of renewable energy projects in the province.

Meiko Electronics on April 8 announced that the company will establish Meiko Electronics Yen Quang as a wholly owned subsidiary in Phu Tho province. The company will be set up by April 25.

The move is in response to the expected growth in demand from customers advancing supply chain localisation within the ASEAN region.

With demand projected to exceed the production capacity of its existing plants as well as those currently under construction, Constructing the new manufacturing plant will be carried out with an investment capital of $50 million.

The company entered Vietnam in 2006 with its first factory in Thach That district on the outskirts of Hanoi, then one of the country’s top 10 foreign-invested projects. Meiko now operates four manufacturing and assembly facilities nationwide.

Meiko Electronics supplies PCPs to major clients like Apple and Samsung. With the new investment in Phu Tho, the Japanese company is strengthening its production base in the country.

According to the Ministry of Finance, Japan remains one of the biggest investors in Vietnam. In the first quarter of 2026, the country invested $191.3 million into the country, accounting for 1.9 per cent of foreign direct investment capital.

Japan’s Fujiya strengthens production base in Vietnam Japanese confectionery maker Fujiya is developing its production base in Vietnam to serve both domestic and export markets.

JETRO signs investment deal with Ho Chi Minh City Japanese investment flows into Ho Chi Minh City are set to receive a boost following a new agreement focused on manufacturing, technology, and innovation.

Sumitomo breaks ground on new industrial park in Thanh Hoa Sumitomo Corporation has broken ground on the first phase of Thang Long Thanh Hoa Industrial Park, a project aimed at attracting supporting industries and high-tech ventures in north-central Vietnam.

The programme, jointly organised by the Agency for Private Enterprise and Collective Economy Development (APED) under the Ministry of Finance and the International Labour Organization (ILO) in Vietnam, seeks to enhance the capacity of small- and medium-sized enterprise (SME) and support institutions to boost productivity improvements and decent work.

Hanoi, home to more than 210,800 active SMEs, accounting for roughly one-fifth of the country’s total, was selected as the venue given its role as Vietnam’s political, economic, and cultural centre, as well as a hub for dynamic manufacturing firms.

The training focuses on equipping participants with practical tools, knowledge, and advisory skills to help SMEs adapt to evolving market demands, particularly in the context of sustainability and global integration.

Key topics include the interlinkages between productivity, digital transformation, green transition, and working conditions; the importance of needs assessments in designing SME support programmes; and the introduction of assessment toolkits.

Participants are also being introduced to emerging market trends and new requirements related to green growth and sustainable development, including compliance with legal frameworks, supply chain standards, and international integration commitments.

In addition, the programme highlights practical and feasible green transition solutions that can help enterprises optimise resource use, reduce waste, improve energy efficiency, and adopt cleaner production practices.

The training also presented the ILO’s Sustaining Competitive and Responsible Enterprises methodology, along with guidance on mobilising resources, ranging from finance and human capital to technology, and addressing challenges in building local enterprise networks.

Beyond technical content, the programme provides a platform for dialogue and networking among business support organisations, enterprises, and experts, fostering greater collaboration within the SME ecosystem.

Speaking at the opening session, Nguyen Xuan Tho, deputy director general of the APED, underscored the comprehensive scope of the training.

He noted that the programme covered critical areas such as enterprise diagnostics and needs assessment; sustainable market trends and “greening” requirements for manufacturing firms; and impact assessment and advisory solutions for dual transformation through the application of environmental, social, and governance reporting frameworks and tools such as the Basic Sustainability Assessment Tool.

“These tools will help enterprises enhance transparency, accountability, and strategic orientation in their sustainable development efforts,” he said.

Tho added that the training adopts flexible and interactive delivery methods, including moderated discussions, case study analysis, and multi-stakeholder exchanges among enterprises, experts, and local support organisations.

The programme also serves as a channel to disseminate key policies and resolutions issued by the Politburo and the National Assembly on private sector development, as well as information on available resources to support SMEs.

“We hope the training will help address practical challenges faced by participants and enable them to better support enterprises,” he said.

Mette Møglestue, Deputy Ambassador of Norway to Vietnam

Sharing international perspectives, Mette Møglestue, Deputy Ambassador of Norway to Vietnam, highlighted the importance of cross-sector and cross-institutional dialogue.

“From Norway’s experience, strong collaboration across stakeholders is essential,” she said. “This programme brings together the right ecosystem, government agencies, experts, business associations, and enterprises, to generate meaningful progress.”

She emphasised that such cooperation was key to scaling up digital and green transitions effectively, while ensuring they are tailored to local conditions.

Meanwhile, Sinwon Park, ILO country director in Vietnam, stressed that transformation processes must remain people-centred.

“Technology and greener production methods should not be seen as ends in themselves,” she said. “They must help enterprises improve competitiveness while enhancing working conditions, occupational safety and health, workplace cooperation, and development opportunities for both workers and managers.”

This approach reflects the ILO’s Productivity Ecosystems for Decent Work framework, which links productivity gains with improved working conditions and responsible business practices.

The Hanoi training is part of a broader series of five capacity-building programmes being rolled out across northern provinces. The initiative targets hundreds of participants, including officials from business support organisations, consultants, and representatives of manufacturing SMEs.

These activities fall under the Productivity Ecosystems for Decent Work project, an ILO initiative funded by the Swiss State Secretariat for Economic Affairs and the government of Norway. The initiative aims to support Vietnam in achieving sustainable productivity growth alongside the promotion of decent work, with the APED serving as the implementing agency.

Through such collaborative efforts, stakeholders expect to strengthen Vietnam’s SME support ecosystem and accelerate the transition towards a more inclusive growth model.

New tax incentives to benefit startups and SMEs Newly-issued Decree 20 introduces a package of tax exemptions and reductions, creating a more favourable legal and financial environment for startups and small and medium-sized businesses.

Haiphong training programme targets productivity and growth On April 2–3, the Department of Private Enterprise and Collective Economy Development under the Ministry of Finance, in collaboration with the Haiphong Union of Science and Technology Associations, held its first training course in Haiphong.

The bank targets outstanding loans approximating $28 billion, up 11.7 per cent, and total deposits of $36.8 billion, an increase of 10.2 per cent. It also aims to keep its on-balance-sheet bad debt ratio below 5 per cent.

These targets are considered conservative compared to previous years, reflecting a balanced approach between growth and system safety, while acknowledging the challenges faced in the recent period.

By the end of 2025, Sacombank reported consolidated pre-tax profit of $305 million, equivalent to 52 per cent of its annual plan. In the fourth quarter alone, the bank posted a loss of more than $132 million, mainly due to a sharp rise in provisioning expenses.

This underscores Sacombank’s proactive and prudent risk management strategy, aimed at strengthening its resilience amid rising market risks and ensuring readiness in handling legacy assets.

The move reflects a strategic focus on asset quality and sustainable medium- to long-term development, rather than short-term profit maximisation, laying the groundwork for balanced benefits among customers, partners, and shareholders.

Hanoi-based LPBank has announced documents for its 2026 annual general shareholders meeting, outlining a modest 5 per cent increase in 2026 profit to $599 million. Credit growth is expected at 11.7 per cent, reaching $17.5 billion, while total assets are projected to rise 1.6 per cent to $24.6 billion.

The bank described 2026 as a pivotal year in its new development phase, building on strong growth momentum in recent years.

LPBank aims to become the leading retail bank in rural areas and tier-2 cities on a digital platform, while ranking among the top five providers of priority banking services in major urban centres.

Despite modest profit growth, this bank plans to pay a cash dividend of up to 30 per cent. Specifically, distributable profit by the end of 2025 is estimated at $376 million, with $358 million proposed for dividend payments at the upcoming 2026 annual general shareholders meeting, scheduled for April 28.

This would mark the highest cash dividend payout in the bank’s history and one of the highest levels in the industry.

Meanwhile, southern lender Eximbank has approved a 2026 business plan targeting pre-tax profit of $163 million, 2.7 times higher than its 2025 result, equivalent to a 169 per cent increase.

By the end of 2026, total assets are expected to reach $12.4 billion, up 13 per cent, while deposits are projected to rise nearly 18 per cent to $9.3 billion, and outstanding loans to increase nearly 17 per cent to $9.14 billion. The bad debt ratio is to be kept below 2 per cent.

In 2025, Eximbank recorded pre-tax profit of $60.47 million, fulfilling just 29.1 per cent of its annual plan. The bank leadership described the year as a challenging yet decisive turning point.

A key highlight was a sharp increase in risk provisioning to $61.04 million, up 57.5 per cent on-year. This deliberate and cautious move was aimed at strengthening financial buffers and enhancing resilience against market volatility.

The higher provisioning costs inevitably reduced profit, but this decline was part of a calculated strategic approach.

Eximbank is currently focusing resources on comprehensive restructuring and system transformation. Operating expenses rose significantly due to investments in high-quality human resources and the implementation of key technology and operational projects to enhance long-term competitiveness.

Meanwhile, ACB targets a 16 per cent increase in its total assets by the end of 2026. Outstanding loans are expected to grow 16 per cent, within the credit growth limit approved by State Bank of Vietnam, while total funding (including valuable papers) is projected to surge 16 per cent.

The bad debt ratio will be kept below 2 per cent, and pre-tax profit is expected to increase 14 per cent compared to 2025, reaching $891 million.

In 2025, ACB saw a slowdown in profit growth, with pre-tax profit declining from $840 million to $782 million, down 7 per cent. In Q4 alone, the bank’s profit declined by nearly 39 per cent on-year.

The sharp decline in Q4, 2025 was mainly due to a surge in credit risk provisioning, which jumped from $5.9 million in Q4/2024 to $78.3 million in Q4/2025, an increase of more than $72 million or 13.2 times higher than the same period a year earlier.

ACB’s leadership acknowledged the short-term impact of the aggressive provisioning but described it as a necessary step.

“The significant increase in provisioning in 2025 is aimed at strengthening the risk buffer. Once this buffer is sufficiently built up, ACB will have greater room to support profitability in 2026, provided that debt recovery efforts are effectively implemented,” a bank executive said.

Deposit rate hikes expected to continue as banks compete for liquidity Deposit rates are expected to trend higher in early 2026 as banks compete for liquidity, raising funding costs and creating upward pressure on lending rates, including mortgages.

Banks expand financial ecosystems to unlock new growth drivers Banks are expanding into insurance, securities, digital assets and fund management to drive growth, but stronger risk governance will be crucial to ensure system stability.

Banks ramp up plans to establish VIFC subsidiaries Banks are accelerating plans to set up subsidiary banks at the Vietnam International Financial Centre to expand the ecosystem and enhance international competitiveness.

Kim Sung Hun, CEO of the group’s subsidiary Amkor Technology Vietnam, requested a meeting on April 6 with Bac Ninh authorities.

Liquefied petroleum gas (LPG) is emerging as a critical contingency fuel for semiconductor factories facing energy shortages, specifically as a reliable backup to power production facilities when electricity grids or natural gas supplies are disrupted.

The semiconductor industry, which requires massive, uninterrupted power for advanced wafer fabrication, is increasingly exploring LPG to prevent high-cost production shutdowns during energy crises, such as those impacting Asia in March-April 2026.

Hun also suggested that Vietnam should provide support at 3 per cent of the capital investment for semiconductors to boost production sustainability and efficiency.

Besides that, the company expects the local authorities to help train and retain talent for the sector.

Nguyen Hong Thai, Secretary of Bac Ninh Party Committee said, “We will instruct the provincial people's committee and relevant departments and agencies to consider and resolve them within their authority, with the view that the province always accompanies and effectively supports businesses investing in the province, and the success of the business is also the success of the province.”

“The provincial people's committee will host a specific working session with the company; for issues beyond its authority, the provincial leadership commits to closely coordinate with relevant ministries and agencies to advise and submit them to the government for consideration and resolution in accordance with regulations, ensuring a balance of interests for the business,” he said.

Amkor Technology opened its factory in Bac Ninh in October 2023. The factory, covering 23 hectares at Yen Phong 2C Industrial Park, offers turnkey solutions from design to electrical testing.

The venture had an initial investment of $530 million. In July 2024, Amkor received an investment certificate for additional investments of $1.07 billion, 11 years earlier than its original plan. The plant has an annual capacity of 420 million items, while Amkor is seeking permission to increase the output to 3.6 billion items annually.

Vietnam’s semiconductor industry has so far recorded foreign direct investment of $14.2 billion across 241 projects, according to the government. The country now has 166 universities offering semiconductor-related courses, enrolling 134,000 students annually.

National steering committee on semiconductor industry development established Prime Minister Pham Minh Chinh signed a decision on August 8 to establish a national steering committee for the semiconductor industry's development.

Amkor Technology in negotiation to export semiconductor products Amkor Technology, which operates a mega factory for semiconductor assembly and testing in the northern province of Bac Ninh, is in negotiation with an additional six partners to export semiconductor products.

Amkor Technology to triple factory output in Vietnam Amkor Technology Vietnam, under US-headquartered semiconductor giant Amkor Technology, is planning to triple the capacity of its semiconductor factory in Vietnam from 1.2 billion to 3.6 billion items.

Amkor Technology seeks approval for importing used machinery Amkor Technology Vietnam, under US-headquartered semiconductor giant Amkor Technology, has proposed that the government allow the importing of machinery, equipment and technological lines used for more than 10 years.

A joint venture between Vinh Phuc Infrastructure Development and International Services JSC (VISIZ) and SHINEC JSC broke ground on Phuc Yen Industrial Park (IP) in Phu Tho province on April 9, following approval from provincial authorities.

The project, covering 111.33 hectares with total investment of over VND1.98 trillion ($80 million), is positioned as a key component of Phu Tho’s industrial strategy, aimed at attracting high value-added sectors including high-tech manufacturing, electronics, precision engineering, supporting industries, and logistics.

Local authorities view the development as part of a broader push to modernise industrial infrastructure and improve competitiveness, particularly as Vietnam seeks to capitalise on global production shifts. Phu Tho, traditionally outside the core industrial belt, is increasingly positioning itself as a gateway connecting Hanoi with northern midland and mountainous regions.

Tran Duy Dong, Chairman of Phu Tho People’s Committee, said the project holds strategic importance within the province’s industrial planning framework. “Phuc Yen Industrial Park is designed to attract clean and high-tech industries, in line with our long-term development orientation. It is not just an infrastructure project, it is also a model for modern, environmentally friendly industrial development,” he said.

“To ensure the effectiveness of this and other IPs, the province is committed to developing synchronised external infrastructure, including transport, electricity, water, and telecommunications. We will prioritise high-tech investment, ensure environmental compliance across all industrial zones, promote the use of renewable energy, and strengthen workforce development alongside social housing for workers,” he added.

The project benefits from strong connectivity, located near Noi Bai–Lao Cai Expressway and approximately 10 minutes from Noi Bai International Airport, with direct links to Hanoi and major manufacturing centres. This positioning is expected to support supply chain efficiency and reduce logistics costs for investors.

Infrastructure within the IP is being developed in a synchronised manner, including internal road systems, high-capacity power supply, water and drainage networks, and a centralised wastewater treatment facility meeting environmental standards. These elements are intended to allow investors to commence operations shortly after land handover.

The development will be implemented in two phases. The first phase, from the first quarter of 2024 to the first quarter of 2026, focuses on legal procedures, land clearance, and initial construction. The second phase, scheduled from the second quarter of 2026 to the first quarter of 2027, will complete technical infrastructure and prepare the site for secondary investors.

Nguyen Hai Tung, general director of VISIZ and representative of the investor consortium, said the park is designed to meet international standards and respond to evolving investor requirements. “We are not simply developing an industrial site, but building a high-tech industrial ecosystem aligned with digital transformation, green transition, and circular economy principles,” he said.

“The park is expected to become an attractive destination for high-quality foreign investment, creating significant employment opportunities and supporting structural economic transformation in the area. Our focus is on delivering a sustainable environment where businesses can operate efficiently and expand over the long term,” he added.

Pham Hong Diep, chairman of Shinec JSC, said the ecological IP model offers a strong competitive advantage in attracting investment, particularly as sustainability becomes a core requirement for global manufacturers. He noted that this approach reduces market risk, as demand for environmentally compliant industrial space continues to grow.

“An eco-IP is inherently more competitive than conventional models, especially in today’s investment landscape. Investors are no longer driven purely by cost, but by long-term sustainability and compliance with ESG standards, so we are confident about market demand,” Diep said.

He added that environmental, social, and governance (ESG) principles are being embedded throughout the entire development process of Phuc Yen Industrial Park, from land clearance and site preparation to infrastructure construction and operation. “We are implementing ESG from the very beginning, not as an add-on but as a core development principle. This ensures that investors can operate in a high-quality, sustainable environment aligned with global standards,” Diep explained.

Once operational, Phuc Yen IP is expected to attract dozens of secondary investors, generate thousands of jobs, and contribute to local budget revenues. The project is also anticipated to stimulate the development of supporting services, urban areas, and commercial activities in Phuc Yen ward and surrounding areas, reinforcing its role as a new industrial growth node in northern Vietnam.

The country's trade outlook is entering a more challenging phase in the second quarter of 2026, with mounting external uncertainties expected to weigh on export performance.

Speaking at the Ministry of Industry and Trade’s regular press briefing on April 9, Tran Thanh Hai, deputy director general of the Agency of Foreign Trade, pointed to three major challenges shaping the near-term outlook.

He noted that global consumption is weakening as inflationary pressures continue to erode purchasing power, despite easing geopolitical tensions in the Middle East. This shift in consumer behaviour is expected to reduce import demand in key markets, directly affecting Vietnam’s exports.

In addition, risks related to raw material supply, particularly oil, remain a concern. Hai explained that oil is a critical input for multiple industries, including chemicals, plastics, and fertilisers, and any supply disruption could significantly increase production costs and compress profit margins.

Rising logistics costs are also re-emerging as a challenge. After a period of stability, transport expenses are increasing again, adding pressure on exporters, especially those operating in low-margin sectors.

However, Hai noted that the outlook is not entirely negative. If geopolitical conditions improve further and oil prices decline, input and logistics costs could ease, creating stronger conditions for export activities.

In this context, he stressed that business adaptability would be critical. “Enterprises need to flexibly adjust their market strategies, improve competitiveness, and make effective use of free trade agreements to sustain growth,” Hai said.

First-quarter data provides additional insight into Vietnam’s trade dynamics. Total import-export turnover reached nearly $250 billion, marking an increase of about 22 per cent on-year and signalling a strong recovery in trade activity.

At the same time, the trade balance recorded a deficit of approximately $3.6 billion, drawing attention as the country continues to target a full-year trade surplus.

Hai noted that this development should be viewed in context, explaining that the first quarter is typically not a period of strong trade surplus, as businesses tend to increase imports of raw materials and capital goods in preparation for production cycles later in the year.

"During the first quarter, even if there is a trade surplus, it is usually not significant. This is the period when enterprises import inputs and invest in equipment for new projects," he said.

This trend has been further reinforced by strong foreign direct investment inflows in 2025. As foreign-invested projects move into the implementation phase, demand for machinery, equipment, and production inputs has risen accordingly.

Data reflects this shift. Imports of electronic components increased by around half, while machinery, equipment, and spare parts rose by approximately 22 per cent. Imports of fuel and animal feed materials also recorded notable growth, all of which are essential inputs for production.

From this perspective, the trade deficit in the first quarter carries more of an investment nature than indicating structural imbalance. Hai underscored that the situation remains under control, despite the rapid pace of import growth.

Nevertheless, pressure is expected to build in the coming quarters. As import volumes rise, the ability of businesses to convert these inputs into exportable output will be crucial in determining whether the trade balance can return to surplus.

Vietnam’s trade performance in 2026 is therefore best understood as being in a transition phase, where short-term challenges coexist with medium-term opportunities driven by overseas funding and industrial expansion.

The venture is structured through a partnership and franchise agreement with Sodiaal Group (France), the owner of the Candia brand, thereby integrating European production and quality standards.

The Be Milk manufacturing plant will be developed in two phases with key highlight of the application of advanced European-standard technologies, supported by a strong network of international partners, including Sodiaal Group (France), IPEM Group (France), Tetra Pak (Sweden), and Takenaka Corporation (Japan).

According to Philippe Phan Van Ho, CEO of Swiss Asia Partner SA, selecting an investment location is not solely based on market potential, but also on the ability to meet long-term operational standards.

“Tay Ninh offers clear development potential in food processing, while Prodezi Industrial Park provides a suitable platform for us to execute the venture with efficiency, stability, and sustainability,” said Ho.

This alignment is reflected in the project’s ability to integrate seamlessly into the ESG-oriented infrastructure of Prodezi Industrial Park.

Wastewater systems are designed to meet environmental standards before connection to centralized treatment facilities, while energy efficiency and resource optimization solutions are embedded to support long-term operational performance. Furthermore, Prodezi’s industrial symbiosis model enables integration with related manufacturing activities, fostering a circular and sustainable production ecosystem.

Truong Khac Nguyen Minh, deputy general director of Prodezi Long An, stated that from the outset, Prodezi has pursued an eco-centric industrial park model, with infrastructure development aligned to environmental, social, and governance standards and industrial symbiosis principles.

“This approach has demonstrated strong compatibility with the requirements of international investors. Swiss Asia Partner SA’s decision to implement its venture at Prodezi is a positive signal, underscoring the broader investment potential of Tay Ninh. Looking ahead, we will continue to enhance our sustainable industrial ecosystem to better meet global investor standards and expand partnerships with international stakeholders,” Minh said.

Once operational, the Be Milk plant is expected to enhance Vietnam’s domestic dairy processing capacity through the transfer of European technologies and quality management practices. It will also strengthen value chain linkages from raw materials to distribution.

At the provincial level, the initiative is anticipated to generate employment, contribute to fiscal revenues, and add a high value-added manufacturing component aligned with Tay Ninh’s strategy to entice high-quality FDI and encourage industrial development.

The event takes place as Tay Ninh continues to strengthen its position as a leading investment destination in Southern Vietnam.

In 2025, the province ranked among the top 10 most attractive localities for large-scale enterprises, with newly registered and adjusted foreign direct investment (FDI) totalling $1.7 billion.

This strong performance is underpinned by ample industrial land availability, continuously improving regional connectivity, and a strategic focus on high value-added manufacturing industries.

At the same time, global FDI flows are increasingly shifting towards projects aligned with Environmental, Social, and Governance (ESG) standards. Tay Ninh’s well-prepared investment infrastructure positions the province to effectively capture this trend and enhance its competitive advantage.

Vietnam’s dairy sector continues to demonstrate robust growth. According to IMARC Group, the country’s dairy market is projected to reach $13.37 billion by 2033, with a compound annual growth rate of 9.5 per cent over 2025-2033.

Amid rising domestic demand and constrained local supply, the dairy processing industry presents significant opportunities for technologically advanced, internationally standardised projects such as Be Milk.

Prodezi Long An JSC, established in April 2016, with main business in real estate, with notable projects including the 400-hectare Prodezi Industrial Park with investment capital of more than VND 4,600 billion ($176 million) and the 100-hectare LA Home Township, launched in early 2024.

Swiss Asia Partner SA is an international investment and financial advisory group headquartered in Lausanne (Switzerland), with an extensive operational network across Europe, Southeast Asia, and the Middle East.

As part of its expansion strategy in Southeast Asia, Swiss Asia Partner SA currently acts as the market development representative and franchisee for the Candia milk and Yoplait yogurt brands of Sodiaal Group (France) - one of Europe's largest dairy groups and a Top 20 global dairy enterprise.

Sodiaal operates under an agricultural cooperative model with a network of over 8,000 member farms, running approximately 70 production facilities across multiple countries, and achieving a consolidated revenue of around around $7.58 billion in 2025.

Sodiaal's ecosystem encompasses a comprehensive value chain, from raw milk production and industrial processing to brand development and international product distribution. Within this ecosystem, Candia stands as one of Sodiaal's flagship brands and is recognised as the leading UHT milk brand in France, currently available in over 60 countries.

Furthermore, Sodiaal also owns Yoplait, one of the world's largest yogurt brands, with a well-established international distribution network across more than 50 countries worldwide.

The significant funding will enable the GEF to bolster investment in nature-positive development, helping developing countries address their most urgent priorities and generate global environmental benefits that help people as well as ecosystems.

Further pledges in support of a robust and ambitious four-year financing round are expected by the GEF Council meeting at the end of May, when the final replenishment package will be approved.

Read the full press release in English, French, or Spanish

"This replenishment sends a clear message: the world is not giving up on nature even in a time of competing priorities. Our donor countries have risen to the challenge and made bold commitments towards a more positive future for the planet. The coming four years of the GEF-9 cycle will reflect this high-ambition push to achieve the 2030 environmental goals," said Claude Gascon, Interim CEO and Chairperson of the GEF.

The GEF-9 investment cycle will cover the period from July 2026 to June 2030. Four overarching priorities will define the ambition and approach for the GEF over the next four years:

• Integration and Integrated Programs
• Blended Finance
• Whole-of-Government and Whole-of-Society Approaches
• Robust Funding for LDCs and SIDS, and a Significant Increase in Support to IPLCs

The 71st GEF Council meeting will be held in Samarkand, Uzbekistan from May 31 to June 3, 2026. The meeting will take place in advance of the Eighth GEF Assembly, when individual country pledges will be publicly announced.

For more information, visit: www.thegef.org

The AI-powered platform, which has provided more than $500 million in funding to online sellers, is known for its pioneering "AI CFO" technology – a real-time financial intelligence engine designed to help businesses plan, forecast, and scale with confidence. What sets the AI CFO apart is its ability to analyze a business in seconds and translate complex financial data into clear, actionable funding pathways.

By adding Temu to the platforms it supports, 8fig is expanding access to growth capital for a broader range of e-commerce sellers across the United States and Canada. Businesses operating on major marketplaces and storefront platforms can now access revenue-based financing and lump-sum financing through the platform.

Small businesses can apply for funding directly by submitting basic business details and securely connecting their bank account via open banking to receive fast assessments and financing decisions.

The AI CFO doesn't just present a single offer; it allows business owners to tailor their funding plan by adjusting amounts, timelines and cash flow structure to match how their business operates. This level of flexibility positions 8fig as more than a traditional funding source, but an active partner in business growth.

This evolution positions 8fig as one of the most adaptive and intelligent capital platforms in the market, combining instant insight, flexible planning and streamlined access to funding from $10,000 to $2 million.

"8fig was built to put sophisticated financial intelligence in the hands of everyday business owners," said Yaron Shapira, Co-Founder and CEO of 8fig.

"The AI CFO can understand a business in seconds, recommend a growth pathway and, most importantly, give the customer full control to shape the funding around their cash flow. Expanding beyond e-commerce means thousands more SMEs can now benefit from this technology."

The expansion follows 8fig's acquisition by Bizcap and its US affiliate NewCo Capital Group — a move that brought 8fig into one of the world's leading fintech ecosystems for non-bank funding. The partnership strengthens 8fig's ability to deliver capital with more speed, reach and operational firepower.

"8fig represents the future of intelligent business funding," said Bizcap's Global Co-Founder and Co-CEO Albert Gahfi.

"By combining the AI CFO's real-time financial intelligence with Bizcap's global scale, we're unlocking a new generation of products that meet the real-world needs of SMEs – online or offline."

8fig will continue to operate under its existing brand and leadership as it accelerates its roadmap, expands into new industries, and brings AI-driven growth tools to a wider universe of small businesses.

If you're an e-commerce business seeking fast, flexible funding, you can apply here. If you're interested in becoming a partner, 8fig is now accepting applications to become a partner.

For more information, visit bizcap.com.au

The DB-1303-O-3001 trial is a randomized, controlled, open-label, multicenter Phase III clinical trial conducted in China. It aims to evaluate the efficacy and safety of trastuzumab pamirtecan compared to trastuzumab emtansine (T-DM1) in patients with HER2-positive unresectable or metastatic breast cancer who have previously received trastuzumab and taxane chemotherapy. As assessed by the Independent Data Monitoring Committee (IDMC), the trial has met its primary endpoint of statistically significant improvement of progression-free survival (PFS, assessed by Blinded Independent Central Review, BICR) for trastuzumab pamirtecan compared to T-DM1 at a pre-specified interim analysis.

Dr. Hua Mu, Global Chief Medical Officer of DualityBio, stated: "China has over 350,000 new breast cancer cases annually [1], representing a high incidence rate and ranking as the second most common cancer among Chinese women. We are delighted to see that DB-1303/T-Pam has achieved a milestone in its commercialization progress, demonstrating its potential to provide an effective new treatment option for breast cancer patients. In the China market, we have entered into a collaboration with 3SBio to jointly advance the commercialization of multiple indications of DB-1303/T-Pam in Chinese mainland, Hong Kong and Macao. Globally, we will continue to deepen our global strategic partnership with BioNTech to further drive the global development of this product. DB-1303/T-Pam is a globally co-developed new drug with strong strategic partners in both China and global markets. We will work closely together to accelerate the product's marketing approval process, maximize its global clinical value, present more treatment options to patients worldwide."

For more information, please visit www.dualitybiologics.com

The approval of TLX101-Px will fulfil a significant unmet medical need for the characterization of recurrent or progressive glioma from treatment related changes in both adult and pediatric patients^[5]. Neuroimaging of glioma with ¹⁸F-FET is already broadly recommended in international clinical practice guidelines – including NCCN Guidelines®^[6] – and TLX101-Px has been granted Orphan Drug^[7] and Fast Track^[8] designations by the FDA.

"There remains a critical unmet need in improving our ability to image residual glioma after treatment," said Thomas Hope, MD, Vice Chair, Department of Radiology and Biomedical Imaging, University of California, San Francisco (UCSF). "We have worked with Telix for the last three years to help leverage our clinical data to help make FET-PET^[9] available to patients in the United States."

Patrick Wen, MD, E. Antonio Chiocca, MD, PhD, Family Endowed Chair in Neuro-Oncology at Mass General Brigham Cancer Institute, added, "Distinguishing tumor progression from treatment-related change remains one of the most challenging aspects of glioma care. PET imaging with ¹⁸F-FET is an important tool in clinical practice worldwide, and the FDA's acceptance of this application is a meaningful step toward broader access for patients and clinicians in the United States."

Kevin Richardson, CEO, Telix Precision Medicine, added, "The FDA's acceptance of our NDA resubmission is an important milestone for Telix. We appreciate the FDA's constructive engagement and look forward to working closely with the Agency to urgently obtain approval and then bring this product to market for the benefit of patients."

Telix's FY 2026 financial guidance does not include any revenue contribution from TLX101-Px.

The company intends to offer 7 million shares at an indicative price range of KRW 12,400 to KRW 14,800 per share, implying a total offering size of approximately KRW 86.8 billion to KRW 103.6 billion. STRADVISION previously received preliminary approval from the Korea Exchange (KRX) on April 2 and will proceed with institutional book-building followed by a public offering ahead of its KOSDAQ listing. KB Securities will serve as the lead underwriter.

STRADVISION develops AI-based vision perception software for automotive applications. Its flagship solution, SVNet, has been adopted in mass production programs with global automotive OEMs, supporting the company's expanding footprint in the global mobility market.

SVNet is a camera-based perception solution that processes visual data in real time to accurately detect and recognize road objects, including pedestrians, vehicles, and lane markings. It serves as a core enabling technology for advanced driver assistance systems (ADAS) and autonomous driving. Built on a lightweight architecture, SVNet delivers reliable performance even in resource-constrained environments while maintaining compatibility across a broad range of hardware platforms.

In addition, STRADVISION has developed its proprietary integrated data pipeline, SVDataFlow, which automates key data processing tasks such as auto-labeling. This enables faster model development cycles while enhancing data-driven performance improvements and responsiveness to customer deployment requirements.

Leveraging technology designed to meet global vehicle safety assessment frameworks such as EURONCAP and regulatory requirements, including FMVSS, STRADVISION's solutions have been deployed across multiple OEM production programs. The company's software is compatible with more than 30 hardware platforms, further expanding its addressable market.

STRADVISION has surpassed 5 million cumulative vehicle deployments worldwide through its partnerships with global OEMs and has secured more than 1,000 patents globally, reinforcing its core Vision AI capabilities and technological barriers to entry.

The company has demonstrated strong growth, achieving a compound annual revenue growth rate (CAGR) of approximately 60% from 2023 to 2025. As adoption of Level 2 and higher ADAS features continues to accelerate, demand for STRADVISION's solutions is expected to grow in tandem with broader market expansion.

"Through mass production programs with global OEMs, we have validated our technology and built a solid foundation for sustainable growth, supported by our strong R&D capabilities and talent," said Junhwan Kim, CEO of STRADVISION.

"We aim to expand beyond Level 2 ADAS into Level 3 and Level 4 autonomous driving through continuous advancements in Vision AI and multi-vision technologies. In addition, we plan to extend our business beyond automotive into new domains including smart infrastructure, special-purpose vehicles, and robotics," he added.

www.stradvision.com

This year's event focused on reviewing the five-year progress of Kia's 'Total Transformation' initiative, following the company's brand relaunch in 2021. Kia also outlined its mid- to long-term growth roadmap across all business sectors.

"Building on the achievements of innovation across all areas over the past five years —including brand, EVs, PBVs, and ESG — EVs, HEVs, autonomous driving, and robotics will serve as key drivers for Kia's fastest growth to date. Even amid the evolving global environment, Kia will proactively respond to changing market conditions through differentiated strategies." – Ho Sung Song, President and CEO of Kia Corporation.

2030 Mid- to Long-Term Business Strategy

Kia aims to pursue a strategy to accelerate exponential growth, targeting global sales of 4.13 million units by 2030 with a 4.5 percent market share. This compares with a sales goal of 3.35 million units with a 3.8 percent market share in 2026.

Kia places customers at the centre of its business strategy and, over the mid- to long-term, the company intends to expand its mobility ecosystem with a strategic focus on PBVs, autonomous driving, and robotics, connecting people and infrastructure to drive enhanced value creation for both customers and wider society.

Overview of Key Announcements at Kia 2026 CEO Investor Day

For more information, visit the Kia Global Newsroom.

According to Atradius Senior Economist Theo Smid, "Our insolvency forecast has deteriorated due to the persistence of adverse economic conditions, including Covid‑related tax debts, rising input costs and ongoing trade tensions. The crisis in the Middle East, together with the associated increase in energy prices, adds to existing pressures. The impact on businesses will depend largely on the length of the conflict."

Atradius' baseline scenario assumes that the current closure of the Strait of Hormuz will begin to normalise from May, with only limited damage to Gulf infrastructure. If the disruption lasts longer, the insolvency projections would need to be revised.

Looking further ahead, the outlook improves in 2027, when insolvencies are projected to decline by 6% as inflation recedes, energy markets normalise and central banks regain room to reduce rates.

Regional outlook

In Europe, Atradius expects the highest rise in Switzerland, Italy and Portugal, while Ireland, Denmark, Norway and the Netherlands are set for decreases. Across the eurozone, companies continue to operate under substantial pressure in 2026. Higher energy prices, driven by disruptions in gas markets linked to the conflict in the Middle East, are feeding through to broader inflation and weighing on margins.

North America remains divided. In the United States, insolvencies are forecast to rise by 8% in 2026. The economic climate remains challenging for companies, with high trade tariffs and increased policy uncertainty continuing to weigh on the operating environment. In contrast, Canada is expected to see a decline in insolvencies as filings continue to normalise following the sharp rise in 2024.

In Asia‑Pacific, most monitored markets are set for decreases as insolvencies begin to retreat from historically high levels. New Zealand and Hong Kong show the strongest downward adjustments, while Australia, Japan and South Korea are likely to normalise more slowly.

For more detailed forecasts by country and region, access the full Atradius Insolvency Outlook.

More information at https://group.atradius.com.

ONC-841 is the world's first and only clinical stage anti-SIGLEC 10 antibody. The drug was initially developed, and is in a Phase 2 trial, for patients with solid tumors. New preclinical research by OncoC4 has revealed ONC-841's novel activity in normalizing microglia's function in clearance of pathogenic protein aggregates in the brain (1, 2). Benefitting from safety data from the oncology study, the new Phase 1/2 AD clinical trial received accelerated clearance to test the safety and clinical activity of the product for AD treatment.

The first study participant was successfully dosed at Xuanwu Hospital of Capital Medical University in China. The Principal Investigators for the clinical study are Professor Yi Tang and Professor Cuibai Wei at the Xuanwu Hospital.

"Extending our clinical study from cancer to AD showcases OncoC4's research engine and Xuanwu Hospital's infrastructure as the world's eminent AD research center. We are extremely grateful to our colleagues at Xuanwu for the collaboration, " said Dr. Yang Liu, CEO and Chief Scientific Officer.

"We are extremely excited to collaborate with OncoC4 to explore the potential of targeting SIGLEC 10, the novel checkpoints of AD pathogenesis, to bring clinical benefit for patients with this devastating illness", added Professor Yi Tang, Executive Vice President and Principal investigator.

More information: www.oncoc4.com.

Strategic Alliance: By Leveraging JW's Strengths in R&D and Commercialization in South Korea, Gan & Lee Will Establish a Strong Commercial Footprint in South Korea's High-Potential Metabolic Disease Market

Under the terms of the agreement, JW Pharmaceutical will be granted the exclusive rights to develop and commercialize Bofanglutide Injection in South Korea. Gan & Lee Pharmaceuticals will receive a one-time, non-refundable upfront payment of USD 5 million. Additionally, Gan & Lee is eligible to receive milestone payments totaling USD 76.1 million, contingent upon research and development progress, regulatory approvals, and commercialization achievements. Following the product's commercial launch, Gan & Lee will also receive tiered royalties based on net sales. The total potential transaction value reaches up to USD 81.1 million (excluding royalties).

This collaboration marks the third overseas out-licensing deal for Gan & Lee's Bofanglutide Injection, following previous partnerships in Latin America and India. According to data from Grand View Research, the GLP-1RA market in the Asia-Pacific region reached USD 5.47 billion in 2025 and is projected to grow to USD 16.95 billion by 2033, representing a compound annual growth rate (CAGR) of 14% [1], making it one of the fastest-growing regions globally. Currently, the treatment penetration rate of GLP-1 drugs remains extremely low, indicating massive growth potential. As a mature market in the Asia-Pacific region, South Korea's GLP-1RA market size reached USD 526 million in 2025 and is expected to increase to USD 1.6 billion by 2033 [2]. With its high acceptance of innovative drugs and strong patient purchasing power, the South Korean market has become a strategic foothold for multinational pharmaceutical companies entering East Asia. This collaboration marks another key step in the rapid global expansion of Gan & Lee's differentiated bi–weekly GLP–1RA, Bofanglutide.

Steady Progress in Global Phase III Clinical Trials; Bi-weekly Dosing Regimen Significantly Enhances Patient Compliance

Currently, as the world's first bi-weekly GLP-1RA to enter Phase III clinical research, Bofanglutide has advanced into the critical Phase III stage of its global development for three proposed indications: obesity/overweight, type 2 diabetes mellitus (T2DM), and obstructive sleep apnea (OSA). Existing clinical data demonstrate that Bofanglutide can effectively reduce body weight and blood glucose levels while comprehensively improving other metabolic parameters, yielding overall metabolic benefits. Its safety and tolerability profiles are consistent with other GLP-1RA class therapies. The bi-weekly dosing regimen further reduces the annual number of injections by 50% compared to mainstream once-weekly GLP-1RAs. This is anticipated to substantially boost patient adherence, offering a more convenient treatment option for the long-term, effective management of metabolic diseases.

As the global burden of metabolic diseases continues to rise, GLP-1 therapies are encountering tremendous market opportunities. South Korea, as one of the world's key pharmaceutical markets, exhibits a robust demand for innovative diabetes and weight-loss therapies. This collaboration will effectively address the clinical and commercial needs of the South Korean market for highly efficacious and convenient treatment regimens.

"This partnership with JW Pharmaceutical marks another pivotal step in the globalization strategy for Bofanglutide," stated Dr. Zhi Li, Chief Business Officer of Gan & Lee Pharmaceuticals. "GLP-1 therapies are reshaping the global treatment landscape for metabolic diseases. The convenience of Bofanglutide's bi-weekly dosing and its compelling clinical benefits will help address the unmet medical needs of South Korean patients. With over 80 years of experience, JW brings deep development and commercial expertise in metabolic diseases—a key factor in our decision to partner with JW."

Young-sub Shin, CEO of JW Pharmaceutical, commented: "This agreement represents a significant milestone in expanding our product portfolio within the rapidly growing therapeutic area of metabolic diseases, particularly diabetes and obesity. JW Pharmaceutical will leverage its established expertise in clinical development and regulatory execution, remaining committed to advancing the development and commercialization of Gan & Lee's Bofanglutide in South Korea, thereby bringing innovative treatment options to South Korean patients."

Proceeds will be strategically allocated to accelerate Oricell's global expansion and clinical development, while strengthening its technological capabilities and paving the way to capital market milestones.

As a frontrunner in cell therapy, OriCell is focused on engineering CAR-Ts with global clinical impact, having already secured confirmatory proof-of-concept (POC) data across multiple pipelines. By leveraging its proprietary triad: the Ori®Ab antibody screening and engineering platform, the Ori®Armoring functional enhancement platform, and the OnGo (Fast) rapid CMC manufacturing expertise, the company has built a differentiated portfolio that positions it at the vanguard of the global CAR-T race.

OriCell's lead asset, Ori-C101, is a GPC3-targeted autologous CAR-T therapy for advanced hepatocellular carcinoma (HCC). Having successfully navigated investigator-initiated trials (IIT) and a registrational Phase 1 study, the program is now gearing up for pivotal trials. Clinical readouts have demonstrated a best-in-class efficacy and safety profile, with data highlighted at major forums including the ASCO Annual Meeting. With these promising results, Ori-C101 is positioned to become the first-in-class CAR-T therapy approved globally for HCC.

Beyond its lead asset, Oricell is aggressively advancing a diverse portfolio of next-generation modalities, including secreted, rapid-production, and in vivo CAR-T programs.

Dr. Huanfeng Yang, Chairman and CEO of Oricell Therapeutics, stated: "This financing is a testament to the global potential of our science and the dedication of our team. As we approach key inflection points in our clinical programs, our priority is clear: expedite the global development of our core assets and deepening our research into revolutionary technologies, including in vivo CAR-T and solid tumor CAR-T. We are committed to delivering transformative therapies that offer real hope to cancer patients worldwide, positioning Oricell as a dominant force in the global immunotherapy arena."

Shan Fu, Managing Partner at Vivo Capital, commented: "While cell therapy is undoubtedly the future of oncology, solid tumors remain the industry's toughest nut to crack. Oricell distinguishes itself not just through best-in-class clinical data for its GPC3 CAR-T, but also through a pragmatic and visionary roadmap for next-generation modalities like in vivo CAR-T. We have high conviction in their integrated 'Platform and Pipeline' strategy and believe they are poised to set the new standard of care in the field. Vivo Capital is eager to deploy our global network to accelerate Oricell's expansion into international markets."

William Hu, Managing Partner at Qiming Venture Partners, stated: "As an early investor that has stood with Oricell since the Pre-A round, we have witnessed every milestone of its journey—from technological exploration to pipeline realization, and from local innovation to global expansion. We look forward to Oricell leveraging breakthrough cell therapy solutions and stronger clinical data to define the next generation of cancer care, bringing hope to patients worldwide."

About Oricell Therapeutics

Oricell is a clinical-stage biotechnology company developing next-generation cell therapies to address unmet needs in oncology and immunology. Powered by a proprietary technology triad: Ori®Ab (antibody discovery), Ori®Armoring (T-cell enhancement), and OnGo CMC (rapid manufacturing), Oricell has advanced a diversified pipeline targeting both solid tumors and hematologic malignancies. This technical prowess and global strategy are exemplified by the development of another core candidate, OriCAR-017. Supported by compelling data from IIT in China, the program paved the way into global development, rapidly securing IND approvals from both China NMPA and US FDA, along with FDA Orphan Drug Designation (ODD) and Fast Track Designation (FTD). OriCAR-017 has demonstrated a favorable safety profile and robust efficacy in both IIT and registrational clinical trials, with data featured at leading global conferences including 2022 ASCO, 2022 EHA, 2024 ASCO, and published in top-tier academic journals The Lancet Haematology. These milestones underscore Oricell' capabilities in regulatory strategy, clinical development, and global execution, reflecting its commitment to transforming the future of cell therapy and delivering new hope to patients worldwide. For more information, please visit: www.oricell.com.

Forward-Looking Statements

This press release contains "forward-looking statements" which are not historical facts, but instead are predictions about future events based on the beliefs as well as assumptions made by and information currently available to the management of Oricell Therapeutics Holdings Limited ("the Company" or "Oricell"). The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of the Company, or industry results, to differ materially from any future results, performance or achievement implied by such forward-looking statements. Any forward-looking statements contained in this press release speak only as of the date of this press release. The Company assumes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

The therapy, known as satri-cel (CT041), is the world's first CAR-T treatment specifically developed for solid tumors targeting Claudin18.2, a biomarker commonly found in gastric (stomach) and pancreatic cancers.

A New Era in Cancer Treatment

CAR-T therapy is a highly personalized treatment that uses a patient's own immune cells, reprogrammed to recognize and attack cancer cells with precision. Unlike traditional therapies, CAR-T cells can expand inside the body and continue to fight cancer over time.

While CAR-T has already transformed outcomes in blood cancers, this new therapy represents a major breakthrough in treating solid tumors, where effective options have historically been limited.

Promising Clinical Results

Clinical studies conducted in China have demonstrated encouraging outcomes for patients with advanced gastric and gastroesophageal cancers:

• Objective response rate (ORR): ~41%, significantly higher than standard treatments
• More than 10x improvement vs. conventional therapies in some comparisons
• Progression-free survival extended to ~4.7 months vs. ~1.7 months with standard care

These results have been presented at leading international conferences and published in top-tier medical journals, highlighting the global significance of this therapy.

Addressing a Major Unmet Need

Advanced gastric and pancreatic cancers remain among the most difficult cancers to treat, with limited effective options in later lines of therapy and poor survival outcomes.

This CAR-T therapy offers a new treatment pathway for patients who have exhausted conventional options.

Who May Benefit

This therapy may be suitable for patients who:

• Have advanced or metastatic gastric or gastroesophageal cancer
• Have received at least two prior lines of treatment
• Show Claudin18.2-positive tumors
• Meet clinical eligibility criteria

Each patient will undergo a detailed medical evaluation to determine suitability.

Looking Ahead

This therapy represents a milestone in oncology, opening the door for CAR-T treatments beyond blood cancers and into solid tumors.

Ongoing research is exploring broader applications, including earlier-stage treatment and additional tumor types.

Full article: https://jiahui.com/en/news/200

Highlights in Q1 include:

• Revenues from PCs grew by 15.6% YoY
• Revenues from gaming businesses grew by 25.4% YoY
• Revenues from commercial PCs ^[2] grew by 34.6% YoY

Acer's strategy to expand multiple business engines continued to gain momentum. Total revenues from businesses other than personal computers ^[3] and displays grew 29.2% YoY in Q1 and contributed 34.6% of the group's total revenues.

Acer's public subsidiaries have announced their March and preliminary Q1 revenues. In March, Acer Gaming successfully listed on the Taiwan Stock Exchange Innovation Board; while Acerpure expects to become listed on the Taipei Exchange (it is currently listed on the Taipei Exchange Emerging Stock Market) later this month. Among its businesses under incubation, Acer ITS Inc. revenue grew 113.8% in Q1 YoY.

The proposed transaction reflects strong confidence in Terra Quantum's differentiated quantum algorithms, software, quantum security, and hybrid quantum-classical solutions, as well as its commercial traction across multiple industries including defence, finance, pharmaceuticals, and logistics.

Upon completion of the transaction, the combined entity will be publicly listed, providing Terra Quantum with enhanced access to capital markets to support its next phase of growth, including product development, global expansion, and strategic acquisitions.

Strategic Rationale

The contemplated business combination is expected to enable Terra Quantum to:

• Accelerate the commercialization of ready to deploy quantum technologies
• Strengthen its balance sheet to support scaling operations globally
• Expand partnerships with enterprise and government customers
• Enhance visibility in the quantum computing sector

Management Commentary

"This milestone marks a significant step forward in Terra Quantum's mission to deliver practical quantum solutions on a global scale today," said Markus Pflitsch, Chairman & Chief Executive Officer of Terra Quantum AG. "Partnering with MLAC II would enable us to accelerate innovation, deepen customer engagement, and expand our global footprint."

Paul Grinberg, Chairman and Chief Executive Officer of MLAC II, added: "We believe Terra Quantum is uniquely positioned at the forefront of the quantum revolution which also has a management team with distinguished backgrounds in both science and the commercialisation of technology. This proposed transaction aligns with our strategy to partner with high-growth, category-defining technology companies that can create significant value."

Advisors

Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, is serving as exclusive financial and capital markets advisor to Terra Quantum. Heussen Rechtsanwaltsgesellschaft mbH, together with Kellerhals Carrard, Winston & Strawn, LLP, and Niedermann Rechtsanwälte, are serving as legal counsel to Terra Quantum.

BTIG is serving as financial and capital markets advisor to MLAC II. Lowenstein Sandler LLP and Lenz & Staehelin are serving as legal counsel to MLAC II.